Introduction {#s1}
============

Chronic obstructive pulmonary disease (COPD) is a common chronic disease characterised by respiratory complaints such as dyspnoea and cough, pulmonary function abnormalities mainly due to nonreversible airway obstruction, and limitations in daily life \[[@C1]\]. It is estimated that ∼328 million people worldwide have COPD \[[@C2]\], and their number is still increasing, leading to high social and economic burdens \[[@C2], [@C3]\].

Three major challenges of COPD care are to reduce the impact of symptoms, to improve health status and health-related quality of life (HRQoL) and to guide patients in their daily life with the consequences of the disease \[[@C4], [@C5]\]. In the Netherlands, as well as in other countries, the care for COPD patients has increasingly moved from hospital to primary care settings \[[@C6], [@C7]\]. In this context, practice nurses in primary care play an important role in the integrated care of COPD patients \[[@C6], [@C8], [@C9]\].

Although the clinical diagnosis of COPD is usually based upon the degree of airflow limitation (*i.e.* the decrease in the forced expiratory volume in 1 s (FEV~1~) and the FEV~1~/forced vital capacity ratio), individual differences in HRQoL can only be partly explained by these clinical parameters \[[@C10]\]. To understand and explain individual differences in presentation and outcomes of COPD among people with the same (medical) disease severity, other models in addition to biomedical perspectives are increasingly used, for example the common sense model by L[eventhal]{.smallcaps} *et al.* \[[@C11]\]. This model provides a dynamic framework for describing and understanding the processes involved in managing health threats \[[@C11], [@C12]\]. The model assumes that, when confronted with health threats, people create personal ideas about their illness and treatment in order to make sense of and manage their situation. These ideas, which often do not match medical views, influence coping behaviours and outcomes \[[@C11], [@C12]\]. These ideas include beliefs about consequences, the ability to control the disease, timeline of the disease, the extent to which the treatment helps in controlling the disease, influence of symptoms, understanding the disease, concerns and emotional responses to the disease \[[@C11], [@C12]\].

Extensive reviews have shown that illness perceptions contribute to individual differences in health outcomes and psychological wellbeing \[[@C13], [@C14]\]. A recent meta-analysis revealed that illness perceptions explained 21--30% of the variance of HRQoL across a range of illnesses \[[@C14]\]. Emotional responses to the disease and perceptions of consequences showed the strongest relationship with outcomes \[[@C14]\]. In a study specifically in COPD patients, perceptions of the consequences, symptoms and treatment control explained a higher percentage (56--59%) of the variance in HRQoL \[[@C15]\]. Moreover, other studies in COPD patients showed that illness perceptions are associated with HRQoL \[[@C15]--[@C22]\]. COPD patients who have positive perceptions about the treatment possibilities, who believe that the impact of COPD on daily life is less serious and who are less emotionally disturbed by their disease experience better HRQoL \[[@C15]--[@C22]\].

Evidence highlights the importance of addressing patients' illness perceptions in order to influence illness-related behaviour and HRQoL in COPD patients \[[@C15], [@C20], [@C23], [@C24]\]. Based on the assumption that illness perceptions can be identified and modified \[[@C12], [@C13]\] and the evidence that changing these perceptions can lead to changes in behaviour, which could lead to better health outcomes \[[@C12], [@C13]\], we believe that illness perceptions should be addressed. However, specific guidelines how to discuss illness perceptions with COPD patients in clinical practice are lacking. Although there are studies evaluating the effectiveness of an illness perception intervention in patients who suffered a heart attack \[[@C25]\] and diabetes patients \[[@C26]\], protocols describing the interventions in detail are not available.

Therefore, we translated the existing evidence into the nurse-led COPD guidance, research on illness perception (COPD-GRIP) intervention \[[@C27], [@C28]\]. This tailor-made intervention starts with assessing and discussing illness perceptions, followed by improving patient\'s understanding of the relationship between perceptions and behaviour, creating an action plan and evaluating the actions \[[@C27], [@C28]\]. The development and experiences of the nurses with the COPD-GRIP intervention are described elsewhere \[[@C28]\].

This cluster randomised trial aimed to assess whether the COPD-GRIP intervention is effective in improving health outcomes of COPD patients in primary care. The hypothesis was that COPD patients who receive the COPD-GRIP intervention would have better health outcomes in terms of health status, HRQoL, daily functioning and health-related behaviours.

Methods {#s2}
=======

Study design and participants {#s2a}
-----------------------------

A two-arm, cluster randomised controlled trial with an intervention period of 6 weeks and follow-up period of 9 months was performed to test whether the nurse-led COPD-GRIP intervention leads to more improved health outcomes in COPD patients in primary care compared to usual nursing care (Netherlands Trial Register NTR 3945). A cluster consisted of a primary care practice or a home care service.

Primary care practices (n=34) and home care services (n=6) were recruited throughout the Netherlands. A practice or home care service was eligible to participate in the study if a practice nurse or respiratory nurse provided consulting hours or home visits to guide COPD patients according to the standard COPD care as described in the Dutch COPD guidelines \[[@C29], [@C30]\]. COPD patients were eligible if they were diagnosed by their general practitioner with mild to severe COPD, grades I to IV, according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines \[[@C4]\]. Other inclusion criteria were age ≥40 years, a lung function test performed ≤1 year prior to enrolment, physical and mental ability to complete the questionnaires and ability to understand and read the Dutch language. Patients were excluded if they had a life-threatening comorbid condition or if they had a primary diagnosis of asthma.

The medical research ethics committee (MREC) of the University Hospital Utrecht concluded that the Medical Research Involving Human Subjects Act (WMO) does not apply to this study; therefore, no WMO approval by the MREC was needed. All participants provided written informed consent to participate in the study.

Setting {#s2b}
-------

Recruitment of primary care practices and home care services started in December 2012 and finished in October 2014. The inclusion of patients started in May 2013 and was closed in December 2014. The follow-up period ended in November 2015.

The practice nurses affiliated in the participating practices and home care services identified eligible COPD patients. Nurses approached all patients that were eligible according to the inclusion criteria.

Written informed consent was obtained from all patients before entry in the study.

The COPD-GRIP intervention was applied by the practice nurses within the context of three extra consultations within ∼6 weeks. After three consultations the intervention was complete. The nurses in the control group were asked to continue their usual nursing care, based on the Dutch general practice COPD guidelines \[[@C30]\], in line with the GOLD guidelines \[[@C4]\].

Intervention {#s2c}
------------

The COPD-GRIP intervention was applied individually for each participant and consisted of three extra face-to-face consultations, each lasting approximately half an hour \[[@C27], [@C28]\] ([table 1](#TB1){ref-type="table"}). These consultations were planned within a ∼3-week interval after inclusion in the study. The intervention has an equivalent structure for all patients. The specific content is individualised, based on a patient\'s responses and the needs of the patient.

###### 

The COPD-GRIP (Chronic Obstructive Pulmonary Disease -- Guidance, Research on Illness Perception) intervention

  --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  The COPD-GRIP intervention is applied individually for each patient and consists of three face-to-face consultations, each lasting ∼30 min\   
  The three consultations are scheduled at ∼3-week intervals\                                                                                   
  The specific content is individualised, based on the patient\'s questions, responses and the needs of the patient                             

  **First consultation: understanding the patient\'s illness perceptions**                                                                      1\) Identifying and understanding patient\'s illness perceptions;\
                                                                                                                                                2) Assessing and discussing illness perceptions using the B-IPQ as a guide for tailoring the intervention

  **Second consultation: identifying the link between illness perceptions and behaviour**                                                       1\) Identifying the link between illness perceptions and behaviour\
                                                                                                                                                2)  Improving the patient\'s understanding of the relationship between their perceptions\
                                                                                                                                                 and their behaviour, by challenging them to draw up an individual care plan (a\
                                                                                                                                                 short-term goal and a long-term goal, with strategies to achieve these)

  **Third consultation: evaluating and discussing the individual care plan**                                                                    1\) Evaluating and discussing the individual care plan\
                                                                                                                                                2)  Evaluating and assessing whether the individual care plan was successful and what new actions are necessary for the future\
                                                                                                                                                3) If the patient did not describe a care plan, discussing actions for the future
  --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------

B-IPQ: Brief Illness Perception Questionnaire.

During the first consultation, illness perceptions were assessed and discussed using the brief illness perception questionnaire (B-IPQ) \[[@C31]\]. In the second consultation, the patients\' understanding of the relationship between their perceptions and their behaviour was discussed. Subsequently, patients were challenged to write an individualised care plan. In the last consultation, the actions the patients had taken to change their perceptions and behaviour were evaluated. An English version of the booklet describing the COPD-GRIP intervention can be found on our website ([www.umcutrecht.nl/griponderzoek](www.umcutrecht.nl/griponderzoek)).

The nurses working in the intervention practices were trained how to apply the COPD-GRIP intervention in a 4-h educational session. During this session the theory that underpins the intervention was explained. Subsequently, the content of the booklet in which the intervention is described was discussed in detail \[[@C28]\]. The stages of the intervention were explained comprehensively and discussed step-by-step. A short animation movie was used to explain the content.

The first consultation of the intervention started shortly after each patient was included.

Randomisation and masking {#s2d}
-------------------------

Randomisation was performed at the level of the primary care practices/home care services before the inclusion of patients. A practice was randomised to the intervention group or control group using a computer-generated randomisation programme with block randomisation, developed by an independent data manager from the University Medical Center Utrecht.

Because of the nature of the intervention, participating nurses and patients could not be blinded to allocation.

### Treatment fidelity {#s2d1}

The following methods were used in order to support treatment fidelity. All nurses in the intervention groups were trained by the same trainer; furthermore, the intervention was described step-by-step in a booklet, which made it easier to use; during the study, all participating practice nurses were contacted by the study nurse monthly by telephone according to the protocol to discuss potential problems and register the number of consultations; finally, the practice nurses were asked to send the individualised care plans back to our centre.

Outcomes {#s2e}
--------

All patient outcomes were collected by questionnaire and sent by post at baseline, 6 weeks, 3 months and 9 months. To prevent missing data, patients received one reminder to complete their questionnaires by means of a telephone call if they did not return the questionnaire within 3 weeks.

The primary outcome was health status on the Clinical COPD Questionnaire (CCQ) \[[@C32]\] at 9 months. The CCQ consists of 10 questions covering three domains: functional state, symptoms and mental state \[[@C32]\]. Secondary outcomes included HRQoL, as measured by the self-administered Chronic Respiratory Disease Questionnaire short form (CRQ-SAS), covering four dimensions: dyspnoea, fatigue, emotional function and mastery \[[@C33]\]. Other secondary outcomes were daily functioning, as measured by the Functional Performance Inventory (FPI) short form \[[@C34]\]. This questionnaire measures the extent to which people engage in their usual day-to-day activities to fulfil usual roles \[[@C34]\]. The B-IPQ \[[@C31]\] was used to asses illness perceptions concerning consequences, timeline, control, identity, concerns, understanding, emotional representations and causal representations. In addition, we measured impact of health education using the Health Education Impact Questionnaire (heiQ) \[[@C35]\]. This questionnaire was developed for the comprehensive evaluation of a patient education programme and covers eight independent dimensions such as positive and active engagement in life, health-directed behaviour, constructive attitudes and approaches, self-monitoring and insight. The Medical Research Council (MRC) dyspnoea score \[[@C36]\] was used to assess dyspnoea.

Statistical analysis {#s2f}
--------------------

Sample size estimates were based on the mean difference in the total CCQ score (primary outcome) between intervention and control groups at 9 months. Sample size estimates for trials that randomise at the level of the individual were first used. Subsequently, to account for cluster randomisation a single inflation factor to the usual sample size was used in the power calculation \[[@C37]\]. The inflation factor is a function of cluster size *m* and intraclass correlation ρ: *n\*=n(m)×m=n*\[1+*(m*−1)ρ\]. The usual sample size of n=100 per trial arm was based on the estimated effect size of 0.39 of the CCQ \[[@C38]\] with α=0.05 and power was 0.80 \[[@C39]\]. Using the usual sample size, an upper estimated value of the intraclass correlation of ρ=0.1 \[[@C37]\] and the inflation factor, power calculations indicated that we needed 38 practice clusters with an average of 10 participants per cluster, leading to a total of 380 participants with a power of 0.80 and α=0.5.

To compare demographic characteristics between the intervention and control group at baseline, a two-sample t-test (α=0.05) for normally distributed data and a Mann--Whitney test for non-normally distributed data were used.

The primary effectiveness analysis was an intention-to-treat analysis of the difference in mean CCQ score between groups at 9 months. Because of repeated measurements for all patients, we used multilevel repeated linear mixed modelling analyses \[[@C40]\].

We assessed the differences between the intervention and usual care group, the effects of measurement time points and whether group differences were dependent on measurement time points by defining a group-by-time interaction. If this group-by-time interaction is not significant, then the development of the outcome over time is not significant (α=0.05), meaning that there is no effect of the intervention. The primary explanatory parameters were the measured time points and the group allocation. These two parameters constitute the basic model. Other parameters (age, sex, MRC dyspnoea score, CRQ-SAS, FPI, B-IPQ and heiQ) were added to the model in order to see if the model improved. This analysis process was first conducted with the primary outcome HRQoL (CCQ). Subsequently, it was repeated with the secondary outcomes HRQoL (CRQ-SAS), daily activities (FPI), illness perceptions (B-IPQ) and health education impact (heiQ). The cluster was represented by a random intercept and a random slope model. The within-patient covariance was set as variance components.

An *a posteriori* defined subgroup analysis was performed to identify whether dyspnoea (MRC dyspnoea score ≤2 or \>2) or sex were moderators.

All analyses were performed using SPSS for Windows (version 23.0; IBM, Armonk, NY, USA).

Results {#s3}
=======

30 primary care practices, five home care services and 204 patients were included in the study ([figure 1](#F1){ref-type="fig"}). These patients met the inclusion criteria and gave their informed consent. However, five (2.5%) patients did not return the baseline questionnaires (n=3 in the intervention group and n=2 in the control group). Subsequently, the baseline analyses were performed with n=199 patients (n=100 in the intervention group and n=99 in the control group).

![Flow chart of the study. PCP: primary care practice; HCS: home care service; COPD-GRIP: Chronic Obstructive Pulmonary Disease -- Guidance, Research on Illness Perception.](00115-2016.01){#F1}

Dropout rates at 9 months were 17% in the intervention group and 14% in the usual-care group ([figure 1](#F1){ref-type="fig"}). Patients who dropped out at 9 months had significantly worse scores on the CCQ, MRC, CRQ-SAS dyspnoea, CRQ-SAS fatigue, FPI, B-IPQ (consequences, concern and emotional response) questionnaires at baseline (p\<0.05). Reasons given by patients for not participating in the study were the burden of filling in the follow-up questionnaires and the study could not be combined with work or family responsibilities.

The mean age was 68 years in the intervention group and 66 years in the usual-care group. The mean FEV~1~ (% predicted) was similar in both study groups (60.6% in the intervention group and 60.5% in the usual-care group). Most of the patients had moderate COPD (n=61 (62.2%) in the intervention group and n=63 (63.6%) in the control group). There were no significant differences between the two groups at baseline, meaning that the two trial arms were well balanced on all variables at patient level ([tables 2](#TB2){ref-type="table"} and [3](#TB3){ref-type="table"}).

###### 

Patient characteristics

                                                 **Intervention**   **Usual care**
  --------------------------------------------- ------------------ ----------------
  **Subjects**                                         100                99
  **Clusters**                                          17                18
  **Age years**                                     68.04±9.64        65.78±9.61
  **Male**                                          45 (45.9)         45 (45.4)
  **FEV**~**1**~ **% predicted**                    60.6±17.6         60.5±20.1
  **GOLD stage^\#^**                                               
   I (mild)                                          9 (9.2)           9 (9.0)
   II (moderate)                                    61 (62.2)         63 (63.6)
   III (severe)                                     23 (23.5)         18 (18.2)
   IV (very severe)                                  5 (5.1)           9 (9.1)
  **Education level**                                              
   Lower secondary or less                          70 (71.4)         65 (65.6)
   Upper secondary                                  18 (18.4)         21 (21.2)
   College/university                               10 (10.2)          8 (8.1)
  **Current smoker**                                27 (27.6)         32 (32.3)
  **Living alone**                                  44 (44.9)         39 (39.4)
  **Contact with healthcare professional**^¶^                      
   Nurse                                               268               195
   GP                                                  323               263
   Physiotherapist                                     414               360
   Dietician                                            6                 33
  **Increase of complaints^+^**                     248 (30.3)        177 (22.3)
  **Hospital admissions^§^**                            13                11
  **Comorbidities**                                                
   Myocardial infarction                             9 (9.1)           6 (6.1)
   Heart failure                                    11 (11.1)          4 (4.1)
   Cerebrovascular accident                          6 (6.1)           3 (3.1)
   Diabetes                                          5 (5.1)          21 (21.1)

Data are presented as n, mean±[sd]{.smallcaps} or n (%). FEV~1~: forced expiratory volume in 1 s; GOLD: Global Initiative for Chronic Obstructive Lung Disease; GP: general practitioner. ^\#^: I (mild): FEV~1~ ≥80% pred; II (moderate): FEV~1~ ≥50% to \<80% pred; III (severe): FEV~1~ ≥30% to \<50% pred; IV (very severe): FEV~1~ \<30% pred; ^¶^: total counts of contacts during study period (intervention period of 6 weeks and 9-month follow-up); ^+^: total counts of reported increase of complaints during study period (intervention period of 6 weeks and 9-month follow-up); ^§^: total counts of reported hospital admissions during study period (intervention period of 6 weeks and 9-month follow-up).

###### 

Baseline measurements

                                             **Intervention**   **Ususal care**   **Reference range**
  ----------------------------------------- ------------------ ----------------- ---------------------
  **CCQ^\#^**                                    1.9±1.2            1.6±1.1              0--6
   Symptoms                                      2.2±1.2            2.0±1.1      
   Functional state                              2.0±1.5            1.7±1.4      
   Mental state                                  1.0±1.3            0.9±1.1      
  **B-IPQ**                                                                      
   Consequences                                  5.5±2.9            4.9±2.8            0.0--10.0
   Timeline                                      9.5±1.6            9.6±1.7            0.0--10.0
   Personal control                              5.5±2.7            6.4±2.3            0.0--10.0
   Treatment control                             7.0±2.6            7.0±2.0            0.0--10.0
   Identity                                      5.4±2.5            4.9±2.7            0.0--10.0
   Concern                                       5.0±3.0            5.4±3.1            0.0--10.0
   Comprehensibility                             7.6±2.4            7.1±2.6            0.0--10.0
   Emotional response                            3.9±3.2            3.6±2.9            0.0--10.0
  **MRC^+^**                                     2.2±1.3            1.9±1.4              0--5
  **CRQ-SAS^§^**                                                                 
   Dyspnoea                                      5.8±1.4            5.6±1.5              1--8
   Fatigue                                       4.5±1.4            4.7±1.4              1--7
   Emotional                                     5.0±1.2            5.2±1.2              1--7
   Mastery                                       5.4±1.2            5.4±1.3              1--7
  **FPI^§^**                                     1.7±0.7            1.8±0.6              1--3
  **heiQ^§^**                                                                    
   Health-directed behaviour                     2.9±0.7            3.1±0.7              1--4
   Positive and active engagement in life        3.0±0.6            3.1±0.5              1--4
   Emotional distress                            3.1±0.7            3.1±0.7              1--4
   Self-monitoring and insight                   3.1±0.4            3.1±0.4              1--4
   Constructive attitudes and approaches         3.2±0.6            3.3±0.5              1--4
   Skill and technique acquisition               3.0±0.4            3.0±0.5              1--4
   Social integration and support                3.0±0.6            3.0±0.6              1--4
   Health service navigation                     3.2±0.4            3.2±0.4              1--4

Data are presented as mean±[sd]{.smallcaps} or n. CCQ: Clinical COPD Questionnaire; B-IPQ: Brief Illness Perception Questionnaire; MRC: Medical Research Council dyspnoea score; CRQ-SAS: self-administered Chronic Respiratory Disease Questionnaire short form; FPI: Functional Performance Inventory; heiQ: Health Education Impact Questionnaire. ^\#^: lower scores mean better health-related quality of life (HRQoL); ^¶^: lower scores on consequences, timeline, identity, concern and emotional response and higher scores on personal control, treatment control and comprehensibility mean more positive perceptions; ^+^: lower scores mean less burden of dyspnoea; ^§^: higher scores mean better HRQoL, functional performance and health education impact.

Primary outcome {#s3a}
---------------

No statistically significant differences in the CCQ were detected between the groups at week 6 or after 3 and 9 months ([table 4](#TB4){ref-type="table"}). Furthermore, the group\*time interaction with the outcome CCQ was not significant (p=0.197), meaning that the COPD-GRIP intervention could not improve health status over time ([figure 2](#F2){ref-type="fig"}).

###### 

Clinical outcomes, corrected for clustering, time, treatment and Medical Research Council dyspnoea score^\#^ for the COPD-GRIP (Chronic Obstructive Pulmonary Disease -- Guidance, Research on Illness Perception) intervention group and the usual-care group

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                 **Baseline**    **6** **weeks**   **3** **months**   **9** **months**   **Mean difference (95% CI)**   **Treatment\*time interaction at 9** **months**\
                                                                                                                                                          **p-values**
  ------------------------------ -------------- ----------------- ------------------ ------------------ ------------------------------ --------------------------------------------------
  **CCQ total**^¶^                                                                                            0.04 (−0.09--0.17)                             0.197

   Intervention                  1.9±1.2             1.8±1.1           2.0±1.3            2.0±1.2                                      

   Usual care                    1.6±1.1             1.7±1.1           1.8±1.1            1.7±1.1                                      

  **CRQ-SAS**^+^ **fatigue**                                                                                 −0.06 (−0.28--0.16)                             0.631

   Intervention                  4.5±1.4             4.5±1.5           4.5±1.5            4.4±1.4                                      

   Usual care                    4.7±1.4             4.8±1.4           4.7±1.3            4.7±1.4                                      

  **CRQ-SAS**^+^ **dyspnoea**                                                                                 0.16 (−0.13--0.04)                             0.162

   Intervention                  5.8±1.4             5.6±1.6           5.6±1.5            5.5±1.6                                      

   Usual care                    5.6±1.5             5.6±1.5           5.6±1.4            5.7±1.5                                      

  **CRQ-SAS**^+^ **emotional**                                                                                0.03 (−0.21--0.27)                             0.463

   Intervention                  5.0±1.2             5.2±1.3           5.2±1.3            5.1±1.3                                      

   Usual care                    5.2±1.2             5.3±1.2           5.2±1.1            5.3±1.2                                      

  **CRQ-SAS**^+^ **mastery**                                                                                  0.09 (−0.11--0.28)                             0.375

   Intervention                  5.4±1.0             5.4±1.1           5.3±1.3            5.3±1.2                                      

   Usual care                    5.4±1.3             5.4±1.3           5.4±1.2            5.5±1.2                                      

  **FPI**^+^                                                                                                 −0.12 (−0.33--0.08)                             0.074

   Intervention                  1.7±0.7             1.6±0.7           1.6±0.7            1.5±0.7                                      

   Usual care                    1.8±0.6             1.8±0.7           1.7±0.7            1.8±0.7                                      

  **B-IPQ^§^** **(control)**                                                                                 −0.22 (−0.70--0.26)                             0.005

   Intervention                  5.5(2.7             6.5±2.1           6.1±2.5            6.6±2.2                                      

   Usual care                    6.4±2.3             6.5±2.1           6.9±1.7            6.2±2.3                                      

  **heiQ**^+^ **(HDB)**                                                                                      −0.12 (−0.26--0.03)                        0.024 (6 weeks)

   Intervention                  2.8±0.7             3.1±0.7           3.0±0.5            2.9±0.8                                      

   Usual care                    3.1±0.7             3.1±0.6           3.1±0.6            3.1±0.6                                      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are presented as mean±[sd]{.smallcaps}, unless otherwise stated. CCQ: Clinical COPD Questionnaire; CRQ-SAS: self-administered Chronic Respiratory Disease Questionnaire short form; FPI: Functional Performance Inventory; B-IPQ: brief illness perception questionnaire; heiQ: Health Education Impact Questionnaire; HDB: health-directed behaviour. ^\#^: lower scores mean less burden of dyspnoea; ^¶^: lower score means better health-related quality of life (HRQoL); ^+^: higher scores mean better HRQoL, functional performance and health education impact; ^§^: lower scores on consequences, identity, concern and emotional response and higher scores on timeline, personal control, treatment control and comprehensibility mean more positive perceptions.

![Clinical COPD Questionnaire (CCQ) scores over time. Data are presented as mean (95% CI).](00115-2016.02){#F2}

Secondary outcomes and subgroup analyses {#s3b}
----------------------------------------

No statistically significant differences were detected between groups in the secondary outcomes HRQoL, as measured by the CRQ-SAS (p=0.162--0.631), and daily activities, as measured by the FPI (p=0.074; [table 4](#TB4){ref-type="table"}).

The analyses showed a statistically significant treatment effect on the health-directed behaviour domain of the heiQ at 6 weeks (p=0.024), as shown in [table 4](#TB4){ref-type="table"}. This means that the COPD-GRIP intervention improved health behaviour shortly after the intervention, but this effect was not preserved over time ([figure 3](#F3){ref-type="fig"}).

![Mean health-directed behaviour scores over time. Data are presented as mean (95% CI).](00115-2016.03){#F3}

Furthermore, there was a statistically significant treatment effect on the personal control domain of the B-IPQ (p=0.005 at 9 months), meaning that the COPD-GRIP intervention improved the perception of the ability to control the disease. However, at 3 months there was a decrease of the perception of control ([figure 4](#F4){ref-type="fig"}), meaning that this result is clinically difficult to interpret.

![Mean Brief Illness Perception Questionnaire (B-IPQ) personal control scores over time. Data are presented as mean (95% CI)](00115-2016.04){#F4}

An *a posteriori* defined subgroup analysis to identify whether dyspnoea (MRC dyspnoea score ≤2 or \>2) or sex are moderators showed no significant effect of the intervention ([table 5](#TB5){ref-type="table"}).

###### 

Subgroup analyses: differences between the COPD-GRIP (Chronic Obstructive Pulmonary Disease -- Guidance, Research on Illness Perception) intervention group and the usual-care group in Clinical COPD Questionnaire scores

  ----------------------------------------------------------------------------------------------------------------------------------
                       **Subjects n**  **Baseline**   **6 weeks**   **3 months**   **9 months**    **Treatment\*time interaction**\
                                                                                                             **p-values**
  ------------------- ---------------- -------------- ------------- -------------- -------------- ----------------------------------
  **MRC score ≤2**                                                                                              0.595

   Intervention              64        1.3±0.7        1.3±0.7       1.3±0.9        1.5±0.8        

   Usual care                68        1.2±0.8        1.2±0.8       1.3±0.8        1.3±0.7        

  **MRC score \>2**                                                                                             0.165

   Intervention              20        3.0±1.1        3.0±1.1       3.2±1.1        3.2±1.1        

   Usual care                23        2.7±0.9        2.9±1.0       3.0±0.9        3.0±1.0        

  **Male**                                                                                                      0.811

   Intervention              33        1.8±1.3        1.4±0.9       1.8±1.3        1.7±1.0        

   Usual care                41        1.7±1.0        1.9±1.1       1.8±1.1        1.8±1.3        

  **Female**                                                                                                    0.126

   Intervention              51        2.2±1.3        2.1±1.2       2.3±1.4        2.2±1.3        

   Usual care                53        1.6±1.1        1.6±1.2       1.8±1.1        1.6±1.0        
  ----------------------------------------------------------------------------------------------------------------------------------

Data are presented as mean±[sd]{.smallcaps}, unless otherwise stated. MRC: Medical Research Council.

Analysis using the minimal clinical important differences (MCID) of 0.4 for the CCQ \[[@C38]\] revealed that 15.7% (n=16) of the patients in the intervention group and 12.9% (n=13) of the patients in the control group had a MCID ≥−0.4, meaning that these patients experienced a better HRQoL compared to baseline. The difference between the groups was not significant.

Discussion {#s4}
==========

This cluster randomised trial revealed that the COPD-GRIP intervention, which focuses on identifying, discussing and evaluating illness perceptions could not improve health status (measured using the CCQ) and HRQoL (measured using the CRQ-SAS) in COPD patients in primary care in the Netherlands. The intervention did demonstrate advantages on the perception of the ability to control the disease and on health-related behaviours in the short term. However, these gains did not persist in the long term.

While the intervention is based on the evidence regarding illness perceptions, health outcomes \[[@C15], [@C17], [@C20], [@C21]\], recent developments concerning patient-centred care \[[@C41], [@C42]\] and was applied in real nursing practice, we could not show benefits in health status and HRQoL in COPD patients.

There are some considerations for not identifying these benefits. Firstly, it could be that the time period of the intervention was too short. In order to achieve more comprehensive guidance and results in the long term, some ongoing support by the nurses and an extension of the follow-up period of the intervention could be needed. Recent evidence from an individual patient data meta-analysis concerning characteristics of self-management interventions in COPD patients shows that there are risk reductions for each increasing contact and each increasing month of duration of a self-management intervention \[[@C43]\]. A Cochrane review \[[@C42]\] shows that the effects of personalised care planning were greater when more stages of the care planning cycle were completed, and when contacts between patients and health professionals were more frequent.

Secondly, we know from our study concerning the exploration of facilitators and barriers of the COPD-GRIP intervention \[[@C28]\] that incorporating the intervention in real nursing practice should have been supported by more intensive training on the job for the nurses, to identify more benefits. Although the nurses perceived the intervention as valuable and feasible, the study revealed that the nurses would like to receive more training in applying the intervention in the future \[[@C28]\].

Thirdly, given the fact that most of the participants had a lower educational level, it could be possible that the intervention was too difficult for them and therefore it could be questioned whether the intervention is appropriate for every patient.

Fourthly, although the CCQ is a highly recommended outcome measure in COPD care and research \[[@C44]\], it could be questioned whether the CCQ is the best possible outcome measure to capture the perceived benefits of the COPD-GRIP intervention that might be achieved by the individual patient. The CCQ measures health status within three domains: symptoms, functional state and mental state. Because the impact of COPD on daily life varies among individuals, and symptoms may change over time as the disease progresses, it could be questioned whether more individualised multidimensional response measures, including domains such as adaptability, adjustment to disease and resilience should be more appropriate. A possible solution could be the use of computerised adaptive testing (CAT) \[[@C45]\]. This method allows more flexibility because the selection of questions depends on a patient\'s response to previous items \[[@C45]\]. A CAT for assessing HRQoL in COPD patients has been developed by P[aap]{.smallcaps} *et al.* \[[@C46]\].

Of particular relevance to this discussion is the recent debate concerning multidimensional measures in COPD by S[pruit]{.smallcaps} *et al.* \[[@C47]\] and A[mbrosino]{.smallcaps} and C[lini]{.smallcaps} \[[@C48]\] who raise the urgent need to develop measures in COPD research that take into account the large heterogeneity of clinical manifestations and individual differences in COPD to do justice to individual responses to therapies.

Our study revealed that the intervention significantly improved health behaviours (measured by the heiQ) in the short term; however, this improvement was not substantial. An effect size of 0.5 or a standard deviation of 0.5 is defined as substantial, and our study showed an effect of 0.3. This small improvement means that some patients changed aspects of their health behaviours. These activities may include changes in diet, exercise and relaxation routines \[[@C35]\]. Although it is not known which specific aspect of the intervention caused this effect, our method and analyses allow us to draw these conclusions. It could be possible that this short-term effect was caused by the extra attention of the nurse, or a better understanding of the relationship between perceptions and behaviour, which could have resulted in a short-term behaviour change.

Furthermore, we did find an effect on perceived ability to control the disease. However, this result is difficult to interpret. The perception of disease control improved at 6 weeks, declined between 6 weeks and 3 months, and at 9 months a small improvement was found. These results show that applying the COPD-GRIP intervention resulted in a higher experienced sense of control directly after the intervention. However, without guidance over time there was no stable improvement. Furthermore, we did not find the same effect on the comparable item heiQ (constructive attitudes and approaches), therefore these results must be addressed with caution. However, we could expect some kind of changes in the control dimension because some people changed their behaviour, which could lead to a subjective sense of control.

Although this trial could not show significant effects on HRQoL, the COPD-GRIP intervention did show some positive findings. During the trial two qualitative studies were performed, in order to identify the experiences of the patients and nurses with the COPD-GRIP intervention \[[@C28]\]. These studies showed various benefits. Patients in the intervention group expressed that they were more aware of the consequences of COPD and they were willing to undertake a more active lifestyle (unpublished data). Simultaneously, the nurses described the intervention as a very useful tool to provide care that is tailored to patients' needs. The COPD-GRIP intervention provides nurses with a structured way to address illness perceptions in daily clinical care in order to understand the behaviour of the patient \[[@C28]\]. The qualitative studies show that the COPD-GRIP intervention improved the communication and interaction between patient and nurse. Given the complex and lifelong nature of COPD, these improvements are relevant.

In the light of the findings of this trial and the positive experiences of the patients as well as the nurses regarding the intervention, it seems reasonable to rethink the process of the intervention by expanding the time period of the intervention and providing intensive training on the job for nurses. This means that they could answer questions and get instructions during their work, including discussion sessions where nurses could share their experiences and learn from colleagues.

Whereas in other patient groups, such as patients recovering from a heart attack \[[@C25]\] and poorly controlled type 2 diabetes patients \[[@C26]\] an illness perception intervention improved health-related outcomes, we could not draw comparable conclusions. P[etrie]{.smallcaps} *et al.* \[[@C25]\] conducted an intervention in heart attack patients at a very early stage after a heart attack and prior to hospital discharge and K[eogh]{.smallcaps} *et al.* \[[@C26]\] studied a family-based intervention in poorly controlled diabetes patients aiming to reach glycaemic control targets. However, there are some important differences between our study and these studies. Firstly, the heart attack patient group is not comparable with the COPD patients. Whereas heart attack patients were confronted with a life-threatening acute disease, COPD patients have a mostly slow progressive disease. Secondly, the outcome measures are not comparable. P[etrie]{.smallcaps} *et al.* \[[@C25]\] used recovery and return to work as an outcome measure and K[eogh]{.smallcaps} *et al.* \[[@C26]\] used glycated haemoglobin in addition to psychological wellbeing and beliefs. In addition, a large cluster randomised trial, undertaken in COPD patients in primary care in the Netherlands assessing the effectiveness of integrated disease management on HRQoL could not show an improvement on the outcome (CCQ) \[[@C49]\]. More or less the same pattern of change in health status improvements in the first follow-up period, but no preservation over time was revealed in a large medication study in COPD patients \[[@C50]\]. These studies show some similarities in the pattern of responses of COPD patients. These results raise the question of what can be done to improve HRQoL in a complex disease such as COPD and to sustain health status improvements after initial treatment. Although improving HRQoL in complex diseases such as COPD is not easy, a vital aspect of care is recognising and acknowledging individual differences. A starting point is exploring the perceptions of patients and assessing their needs as described by themselves.

Strengths and limitations of this study {#s4a}
---------------------------------------

To best of our knowledge, this is the first study assessing the effect of an individualised illness perception intervention in COPD patients in primary care. Strengths of this study include embedding the clinical trial in regular nursing practice and the inclusion of a wide range of patient outcome measures relevant for primary-care nursing. Another strength is the operationalisation of the crucial, but rather neglected theoretical concept of illness perceptions within patient-centred care by identifying, discussing and evaluating illness perceptions. Additionally, we applied sophisticated multilevel and longitudinal analyses to assess the effectiveness of the intervention.

Despite our expectations and effort, we did not succeed in including the number of patients calculated in the power calculation, which is a limitation of this study. Recruitment of patients was performed by the practice nurses by means of professional invitation. Despite the commitment of the general practitioners and the practice nurses, the heavy workload for practice nurses in primary care may have contributed to a suboptimal recruitment of patients. Subsequently, it could be possible that we missed a real effect by including insufficient numbers. Dropouts after 9 months were low; however, their scores at baseline were significantly worse. This could raise questions about generalisability. However, incorporating baseline scores in the analyses did not result in treatment effects, indicating that it is unlikely that dropout rates biased the results. Furthermore, we have no information about the patients who did not take part in the trial; in other words, we cannot identify characteristics of nonresponders. Subsequently, we could not analyse whether these characteristics could influence the effect of the study.

Another limitation is the lack of a detailed description of the treatment fidelity in this study. Although we used a standardised approach in the educational sessions and the protocol of the intervention, there is no insight into the exact content and nature of the consultations. As a consequence, it is not known if the nurses applied the intervention as it was described in the booklet. However, all patients within the intervention group (n=100) received the additional consultations. These patients were challenged (not forced) to draw up an individualised care plan. Finally, we received 83 out of 100 individualised care plans back, meaning that a large number of patients within the intervention group described a care plan together with the nurses, as recommended in the intervention tool.

Conclusion {#s4b}
----------

The COPD-GRIP intervention, practiced by nurses, could not improve health status and HRQoL in COPD patients in primary care in the Netherlands. The intervention does influence the ability to control the disease and health-directed behaviour in the short term. Therefore, taking illness perceptions into account when stimulating healthy behaviours in COPD patients should be considered. Further study on illness perceptions influencing health status and HRQoL is needed.
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